Surely companies that have the potential demand, could set something up with hospitals for their patients. It’s not like leukapheresis is some high tech new thing. If there would be a bottleneck, I’d expect that to be solved fairly quickly with key facilities where brain surgery is being done. That is not going to be a barrier to market. Plus they would surely prioritize.